71 related articles for article (PubMed ID: 24098025)
21. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.
Jiang S; Pei L; Yang ZL; Liu G
Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038
[TBL] [Abstract][Full Text] [Related]
22. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.
Okudela K; Woo T; Mitsui H; Tajiri M; Masuda M; Ohashi K
Pathol Int; 2012 Dec; 62(12):792-801. PubMed ID: 23252868
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY
J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
Srivastava VK; Nalbantoglu J
Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
[TBL] [Abstract][Full Text] [Related]
25. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the transcription factor Sp1 suppresses colon cancer stem cell growth and induces apoptosis in vitro and in nude mouse xenografts.
Zhao Y; Zhang W; Guo Z; Ma F; Wu Y; Bai Y; Gong W; Chen Y; Cheng T; Zhi F; Zhang Y; Wang J; Jiang B
Oncol Rep; 2013 Oct; 30(4):1782-92. PubMed ID: 23877322
[TBL] [Abstract][Full Text] [Related]
27. Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis.
Bellizzi A; Sebastian S; Ceglia P; Centonze M; Divella R; Manzillo EF; Azzariti A; Silvestris N; Montemurro S; Caliandro C; De Luca R; Cicero G; Rizzo S; Russo A; Quaranta M; Simone G; Paradiso A
J Cell Physiol; 2013 Feb; 228(2):408-15. PubMed ID: 22740326
[TBL] [Abstract][Full Text] [Related]
28. Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer.
Galizia G; Gemei M; Del Vecchio L; Zamboli A; Di Noto R; Mirabelli P; Salvatore F; Castellano P; Orditura M; De Vita F; Pinto M; Pignatelli C; Lieto E
Arch Surg; 2012 Jan; 147(1):18-24. PubMed ID: 22250106
[TBL] [Abstract][Full Text] [Related]
29. The relationship of CD133, histone deacetylase 1 and thrombospondin-1 in gastric cancer.
Eto S; Yoshikawa K; Shimada M; Higashijima J; Tokunaga T; Nakao T; Nishi M; Takasu C; Sato H; Kurita N
Anticancer Res; 2015 Apr; 35(4):2071-6. PubMed ID: 25862862
[TBL] [Abstract][Full Text] [Related]
30. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
[TBL] [Abstract][Full Text] [Related]
31. A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.
Ernst A; Aigner M; Nakata S; Engel F; Schlotter M; Kloor M; Brand K; Schmitt S; Steinert G; Rahbari N; Koch M; Radlwimmer B; Weitz J; Lichter P
Pathology; 2011 Apr; 43(3):220-7. PubMed ID: 21436631
[TBL] [Abstract][Full Text] [Related]
32. [Expression of AC133 vs. CD34 in acute childhood leukemias].
Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
Jao SW; Chen SF; Lin YS; Chang YC; Lee TY; Wu CC; Jin JS; Nieh S
Ann Surg Oncol; 2012 Oct; 19(11):3432-40. PubMed ID: 22739652
[TBL] [Abstract][Full Text] [Related]
34. Proteomic profiling of tumor-initiating cells in HT-29 human colorectal cancer cells.
Lee HN; Park SH; Lee EK; Bernardo R; Kim CW
Biochem Biophys Res Commun; 2012 Oct; 427(1):171-7. PubMed ID: 22995320
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients.
Bin Z; Guangbo Z; Yan G; Huan Z; Desheng L; Xueguang Z
J Surg Res; 2014 May; 188(2):396-403. PubMed ID: 24630518
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of CD133 expression in gastric carcinoma.
Ishigami S; Ueno S; Arigami T; Uchikado Y; Setoyama T; Arima H; Kita Y; Kurahara H; Okumura H; Matsumoto M; Kijima Y; Natsugoe S
Anticancer Res; 2010 Jun; 30(6):2453-7. PubMed ID: 20651407
[TBL] [Abstract][Full Text] [Related]
37. Capturing cancer stem cells.
Nat Med; 2008 Aug; 14(8):814. PubMed ID: 18685595
[No Abstract] [Full Text] [Related]
38. Downregulation of Prominin 1/CD133 expression in colorectal cancer by NSAIDs following short-term preoperative treatment.
Lönnroth C; Andersson M; Nordgren S; Lundholm K
Int J Oncol; 2012 Jul; 41(1):15-23. PubMed ID: 22552364
[TBL] [Abstract][Full Text] [Related]
39. Cell cycle analysis of the CD133(+) and CD133(-) cells isolated from human colorectal cancer.
Gharagozloo M; Mirzaei HR; Bagherpour B; Rezaei A; Kalantari H; Sanei MH; Hosseini M; Mohajeri G; Tabatabai A; Hashemi M
J Cancer Res Ther; 2012; 8(3):399-403. PubMed ID: 23174722
[TBL] [Abstract][Full Text] [Related]
40. Correlation between glioblastoma stem-like cells and tumor vascularization.
He H; Niu CS; Li MW
Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
